(firstQuint)Ixabepilone and SBRT For Metastatic Breast Cancer.

 Ixabepilone is a FDA approved drug for the treatment of metastatic or locally advanced breast cancer after failure of chemotherapy.

 SBRT is a treatment method to deliver a high dose of radiation to the target, utilizing either a single dose or a small number of treatments with a high degree of precision within the body.

 The combination of Ixabepilone with SBRT is not an approved treatment at this time.

.

 Ixabepilone and SBRT For Metastatic Breast Cancer@highlight

This study is being done to find the effect of Stereotactic body radiation therapy (SBRT) in combination with Ixabepilone for women with triple negative metastatic breast cancer.

